Edap Tms (NASDAQ:EDAP – Get Free Report) released its quarterly earnings results on Thursday. The medical equipment provider reported ($0.05) earnings per share for the quarter, topping analysts’ consensus estimates of ($0.11) by $0.06, Zacks reports. Edap Tms had a negative return on equity of 44.21% and a negative net margin of 34.92%.
Edap Tms Stock Up 17.3 %
NASDAQ EDAP opened at $2.40 on Thursday. The company has a quick ratio of 1.46, a current ratio of 2.18 and a debt-to-equity ratio of 0.08. The business’s fifty day simple moving average is $2.42 and its 200-day simple moving average is $2.52. Edap Tms has a 52 week low of $1.96 and a 52 week high of $8.50. The firm has a market cap of $89.20 million, a PE ratio of -3.65 and a beta of 0.37.
Analyst Upgrades and Downgrades
Separately, StockNews.com initiated coverage on shares of Edap Tms in a report on Thursday, March 20th. They issued a “hold” rating for the company.
Edap Tms Company Profile
EDAP TMS SA is a holding company, which, through its subsidiary, engages in the development, production, and marketing of minimally invasive medical devices for urological diseases. It operates through the High Intensity Focused Ultrasound (HIFU) and Urology Devices and Services (UDS) segments. The HIFU segment develops, manufactures, and markets devices for the minimally invasive ablation of certain types of localized tumors using HIFU technology.
Recommended Stories
- Five stocks we like better than Edap Tms
- How to Calculate Stock Profit
- How China’s Recovery Could Boost These 3 Platinum Plays
- How to Read Stock Charts for Beginners
- Fortinet: A Top Cybersecurity Stock With Growth Catalysts
- What is the MACD Indicator and How to Use it in Your Trading
- 4 Reasons Amazon Stock Can’t Be Ignored Right Now
Receive News & Ratings for Edap Tms Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Edap Tms and related companies with MarketBeat.com's FREE daily email newsletter.